The Anti-Venom Market is expected to grow at a CAGR 6.5% during the forecast period of 2018–2023. Anti-venom is made up of hyperimmune globulins and various other proteins extracted from the serum of various animals. In the process animals have been immunized with the venom of a snake, and then proteins are extracted from it.
Anti-venom is currently the cornerstone of therapy for the victims of venomous snake bites and has reduced the mortality of this condition. It can be species-specific, regional, or polyvalent. For instance, anti-venom directed against coral snake venom is regenerated by immunizing horses with venom from the eastern coral snake i.e. Micrurus fulvius. The use of anti-venom is associated with various adverse reactions and so is given to only those victims who develop local, systemic, or laboratory evidence of envenoming.
Get Exclusive Sample Pages @ https://www.marketresearchfuture.com/sample_request/5859 .
The use of epinephrine, corticosteroids, and antihistamines is also recommended before anti-venom administration as it helps to reduce the occurrence and severity of acute or delayed hypersensitivity reactions which may occur in 20 to 90% of cases.
According to the World Health Organization (WHO), snake antivenom immunoglobulins is the only specific treatment for envenoming by snakebites. It is also estimated that nearly 4.5 to 5.4 million people are bitten by snakes in a year, and around 1.8 to 2.7 million out of them develop clinical illness after a snakebite.
It is noted that the increasing cases of snake bites and increasing government funding for R&D are the key factors driving the anti-venom market.
Various other factors such as the increasing patient pool, unmet medical needs, increasing awareness about antivenoms, enhancing regulatory framework, and increasing government assistance are continuously contributing to the growth of the global anti-venom market.
Despite these drivers, there are some setbacks associated with the global anti-venom market. The high cost of available anti-venom, strict FDA regulations, difficult preparation of anti-venoms, and poor healthcare system in low- and middle-income countries may hinder the growth of the market to a considerable extent.
MAJOR TABLE OF CONTENT FOR ANTI-VENOM MARKET RESEARCH REPORT – FORECAST TO 2023:
Chapter1. Report Prologue
Chapter2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
LIST OF TABLES
Table 1 Anti-Venom Industry Synopsis, 2017–2023
Table 2 Anti-Venom Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Anti-Venom Market, By Region, 2017–2023, (USD Million)
Table 4 Anti-Venom Market, By Type, 2017–2023, (USD Million)
Table 5 Anti-Venom Market, By Type Of Species, 2017–2023, (USD Million)
Ask Question to Expertise @ https://www.marketresearchfuture.com/enquiry/5859 .
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Anti-Venom Market
Figure 3 Segmentation Market Dynamics For Anti-Venom Market
Figure 4 Global Anti-Venom Market Share, By Type 2016
Figure 5 Global Anti-Venom Market Share, By Type Of Species 2016
Figure 6 Global Anti-Venom Market Share, By Mode Of Action 2016
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –